trial · primary record
PF-08634404
Endometrial Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2031-01-30 |
| Primary endpoint | Progression-Free Survival (PFS) using RECIST v1.1 as assessed by Blinded Independent Central Review (BICR) |
| Registry ID | NCT07578649 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:44.485Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07578649
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.